CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,054 | -17.9% | 1,984 | +1.6% | 0.00% | -50.0% |
| Q2 2023 | $109,641 | +21.9% | 1,953 | -1.8% | 0.00% | +100.0% |
| Q1 2023 | $89,917 | +10.2% | 1,988 | -1.0% | 0.00% | 0.0% |
| Q4 2022 | $81,625 | -34.7% | 2,008 | +5.0% | 0.00% | -50.0% |
| Q3 2022 | $125,000 | +5.9% | 1,913 | -1.6% | 0.00% | 0.0% |
| Q2 2022 | $118,000 | +4.4% | 1,944 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $113,000 | +113.2% | 1,796 | +155.5% | 0.00% | +100.0% |
| Q4 2021 | $53,000 | -55.1% | 703 | -33.1% | 0.00% | -50.0% |
| Q3 2021 | $118,000 | -58.9% | 1,051 | -40.6% | 0.00% | -60.0% |
| Q2 2021 | $287,000 | -100.0% | 1,770 | -78.7% | 0.01% | -44.4% |
| Q1 2021 | $1,012,330,000 | +722992.9% | 8,308 | +806.0% | 0.01% | +200.0% |
| Q4 2020 | $140,000 | +351.6% | 917 | +145.8% | 0.00% | +200.0% |
| Q3 2020 | $31,000 | +40.9% | 373 | +24.3% | 0.00% | 0.0% |
| Q2 2020 | $22,000 | +83.3% | 300 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -33.3% | 300 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $18,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | +116.7% | 300 | +200.0% | 0.00% | – |
| Q2 2018 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |